Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1951 1
1957 1
1961 1
1970 1
1978 1
1983 1
1989 1
1991 4
1992 1
1993 2
1994 2
1996 4
1997 7
1998 5
1999 2
2000 4
2001 12
2002 2
2004 5
2005 6
2006 8
2007 8
2008 4
2009 6
2010 6
2011 15
2012 9
2013 5
2014 7
2015 11
2016 12
2017 23
2018 24
2019 22
2020 24
2021 11
2022 17
2023 18
2024 22
2025 2

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

287 results

Results by year

Filters applied: . Clear all
Page 1
Cabozantinib (XL184), a novel MET and VEGFR2 inhibitor, simultaneously suppresses metastasis, angiogenesis, and tumor growth.
Yakes FM, Chen J, Tan J, Yamaguchi K, Shi Y, Yu P, Qian F, Chu F, Bentzien F, Cancilla B, Orf J, You A, Laird AD, Engst S, Lee L, Lesch J, Chou YC, Joly AH. Yakes FM, et al. Among authors: joly ah. Mol Cancer Ther. 2011 Dec;10(12):2298-308. doi: 10.1158/1535-7163.MCT-11-0264. Epub 2011 Sep 16. Mol Cancer Ther. 2011. PMID: 21926191
[Oral cancer: Risk factors and management].
Paré A, Joly A. Paré A, et al. Among authors: joly a. Presse Med. 2017 Mar;46(3):320-330. doi: 10.1016/j.lpm.2017.01.004. Epub 2017 Feb 21. Presse Med. 2017. PMID: 28233703 French.
Arginine metabolism regulates human erythroid differentiation through hypusination of eIF5A.
Gonzalez-Menendez P, Phadke I, Olive ME, Joly A, Papoin J, Yan H, Galtier J, Platon J, Kang SWS, McGraw KL, Daumur M, Pouzolles M, Kondo T, Boireau S, Paul F, Young DJ, Lamure S, Mirmira RG, Narla A, Cartron G, Dunbar CE, Boyer-Clavel M, Porat-Shliom N, Dardalhon V, Zimmermann VS, Sitbon M, Dever TE, Mohandas N, Da Costa L, Udeshi ND, Blanc L, Kinet S, Taylor N. Gonzalez-Menendez P, et al. Among authors: joly a. Blood. 2023 May 18;141(20):2520-2536. doi: 10.1182/blood.2022017584. Blood. 2023. PMID: 36735910 Free PMC article.
Pourquoi et comment améliorer l’information des patients et de leurs aidants au bon usage de leurs dispositifs médicaux tout au long du parcours de soin ?
Thiveaud D, Orlikowski D, Ollé F, Camus D, Josseran A, Degon PF, Ferracci C, Fraysse JL, Germe AF, Grumblat A, Guido-Morin P, Jarraya B, Joly AS, Lanier C, Pelayo S, Racle G, Teyssie M. Thiveaud D, et al. Among authors: joly as. Therapie. 2023 Jan-Feb;78(1):39-52. doi: 10.1016/j.therap.2022.10.070. Epub 2022 Nov 1. Therapie. 2023. PMID: 36424211 French. No abstract available.
Sirolimus (Rapamycin) for Slow-Flow Malformations in Children: The Observational-Phase Randomized Clinical PERFORMUS Trial.
Maruani A, Tavernier E, Boccara O, Mazereeuw-Hautier J, Leducq S, Bessis D, Guibaud L, Vabres P, Carmignac V, Mallet S, Barbarot S, Chiaverini C, Droitcourt C, Bursztejn AC, Lengellé C, Woillard JB, Herbreteau D, Le Touze A, Joly A, Léauté-Labrèze C, Powell J, Bourgoin H, Gissot V, Giraudeau B, Morel B. Maruani A, et al. Among authors: joly a. JAMA Dermatol. 2021 Nov 1;157(11):1289-1298. doi: 10.1001/jamadermatol.2021.3459. JAMA Dermatol. 2021. PMID: 34524406 Free PMC article. Clinical Trial.
Microbe-mediated intestinal NOD2 stimulation improves linear growth of undernourished infant mice.
Schwarzer M, Gautam UK, Makki K, Lambert A, Brabec T, Joly A, Šrůtková D, Poinsot P, Novotná T, Geoffroy S, Courtin P, Hermanová PP, Matos RC, Landry JJM, Gérard C, Bulteau AL, Hudcovic T, Kozáková H, Filipp D, Chapot-Chartier MP, Šinkora M, Peretti N, Boneca IG, Chamaillard M, Vidal H, De Vadder F, Leulier F. Schwarzer M, et al. Among authors: joly a. Science. 2023 Feb 24;379(6634):826-833. doi: 10.1126/science.ade9767. Epub 2023 Feb 23. Science. 2023. PMID: 36821686
Early patient access to health technologies: Is innovation needed for early management?
Adenot I, Camus D, Épis de Fleurian AA, Tassy D; participants of Giens XXXV Round Table 'Health technologies'; Bourguignon S, Chabin N, Chambrin PY, Costagliola D, Huot L, Joly AS, Le Lous G, Martelli N, Orlikowski D, Petit V, Puc C, Roussel C, Wilquin-Bequet F. Adenot I, et al. Among authors: joly as. Therapie. 2020 Jan-Feb;75(1):71-83. doi: 10.1016/j.therap.2019.11.008. Epub 2019 Dec 16. Therapie. 2020. PMID: 32044105 Review. French.
Alternative splicing, FOXP3 and cardiovascular disease.
Joly AL, Andersson J. Joly AL, et al. Aging (Albany NY). 2019 Apr 12;11(7):1905-1906. doi: 10.18632/aging.101897. Aging (Albany NY). 2019. PMID: 30981208 Free PMC article. No abstract available.
T cell responses at diagnosis of amyotrophic lateral sclerosis predict disease progression.
Yazdani S, Seitz C, Cui C, Lovik A, Pan L, Piehl F, Pawitan Y, Kläppe U, Press R, Samuelsson K, Yin L, Vu TN, Joly AL, Westerberg LS, Evertsson B, Ingre C, Andersson J, Fang F. Yazdani S, et al. Among authors: joly al. Nat Commun. 2022 Nov 8;13(1):6733. doi: 10.1038/s41467-022-34526-9. Nat Commun. 2022. PMID: 36347843 Free PMC article.
Fecal Microbiota Transplantation for Recurrent Clostridioides difficile Infection Can Be the Best Therapeutic Option in Severely Immunocompromised Patients Depending on a Case-by-Case Assessment of the Benefit-to-Risk Ratio.
Benech N, Cassir N, Galperine T, Alric L, Scanzi J, Sokol H; French Fecal Transplant Group. Benech N, et al. Gastroenterology. 2024 Aug;167(3):627-628. doi: 10.1053/j.gastro.2024.04.022. Epub 2024 Apr 26. Gastroenterology. 2024. PMID: 38679396 No abstract available.
287 results